Thomas C. Wilder - 13 Feb 2026 Form 4 Insider Report for Penumbra Inc (PEN)

Reporting relationship: Director
Issuer ticker: PEN
Reported as of: 13 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Feb 2026, 20:03:38 UTC
Prior SEC filing: 06 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Johanna Roberts, as attorney-in-fact for Thomas C. Wilder

Key filing fact

Thomas C. Wilder filed Form 4 for Penumbra Inc (PEN) on 18 Feb 2026.

Key facts

This page summarizes Thomas C. Wilder's Form 4 filing for Penumbra Inc (PEN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Feb 2026, 20:03.

Change

Previous filing in this sequence was filed on 06 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001491299 Primary reporting owner

Wilder Thomas

Relationship: Director
Address: ONE PENUMBRA PLACE, ALAMEDA
Signature: /s/ Johanna Roberts, as attorney-in-fact for Thomas C. Wilder
Signature date: 18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PEN transaction

Common Stock

Award

Transaction value: $0
Shares: +589
Change %
Price: $0.000000
Shares after: 589
Date: 13 Feb 2026
Ownership: Direct
Footnotes: F1, F2

PEN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,506
Date: 13 Feb 2026
Ownership: By Trust
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Mr. Wilder's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Mr. Wilder's continued service as director through such date.

Footnote F2

A portion of these shares is subject to vesting.

Footnote F3

Shares are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006.